• (PLX AI) – Coloplast is a solid defensive stock with potential for nice growth generation, analysts at Handelsbanken said.
  • • The analysts maintained a hold rating on the stock, with price target DKK 1,100
  • • By acquiring Atos Medical, Coloplast secures access to another strategic business area in a chronic ailment segment, Handelsbanken said
  • • The deal makes good strategic sense and will support Coloplast's revenue and product portfolio: Handelsbanken
  • • Coloplast was down 0.4% at DKK 1,111.50 in early trading today

Quelle: PLX AI